Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,805 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reliable Performance of mALBI Grade-Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First-Line Treatment: Comparative Analysis of 13 Risk Models.
Hatanaka T, Kakizaki S, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Toyoda H, Ogawa C, Nishikawa H, Nishimura T, Kawata K, Kosaka H, Naganuma A, Yata Y, Ohama H, Kuroda H, Matono T, Tanaka K, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Kumada T; Real‐life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hatanaka T, et al. Among authors: tanaka k. J Gastroenterol Hepatol. 2025 Jan 6. doi: 10.1111/jgh.16871. Online ahead of print. J Gastroenterol Hepatol. 2025. PMID: 39762722
The Case | A patient with chronic kidney disease and new-onset heart failure.
Watanabe S, Sawa N, Hiramatsu R, Oba Y, Mizuno H, Kurihara S, Inoue N, Sekine A, Tanaka K, Yamanouchi M, Hasegawa E, Suwabe T, Wada T, Sugimoto I, Ubara Y. Watanabe S, et al. Among authors: tanaka k. Kidney Int. 2025 Jan;107(1):195-196. doi: 10.1016/j.kint.2024.10.014. Kidney Int. 2025. PMID: 39746744 No abstract available.
Survivin as a therapeutic target for neuroendocrine neoplasms.
Hane Y, Tsuchikawa T, Nakamura T, Hatanaka KC, Sasaki K, Kawai N, Takeuchi S, Tanaka K, Nakanishi Y, Asano T, Noji T, Shichinohe T, Hatanaka Y, Hirohshi Y, Torigoe T, Hirano S. Hane Y, et al. Among authors: tanaka k. Neuroendocrinology. 2025 Jan 2:1-31. doi: 10.1159/000543270. Online ahead of print. Neuroendocrinology. 2025. PMID: 39746333
Profiling of the microbes on the surface of smartphone touchscreens.
Takahashi N, Wakui A, Sekizawa Y, Kawachi M, Sekiguchi M, Abe T, Sato A, Miyazawa M, Imai M, Kaku N, Maruyama S, Sano H, Kakihara N, Washio J, Abiko Y, Tanaka K, Takahashi N, Sato T. Takahashi N, et al. Among authors: tanaka k. J Oral Biosci. 2024 Dec 30:100607. doi: 10.1016/j.job.2024.100607. Online ahead of print. J Oral Biosci. 2024. PMID: 39743204
Impact of radiotherapy-related late toxicities of skin and soft tissue in the neck on quality of life in head and neck cancer patients: a multi-institutional observational study in Japan.
Higashino T, Wakabayashi M, Zenda S, Yasunaga Y, Araki J, Mukaigawa T, Onitsuka T, Nakagawa M, Hamahata A, Narita K, Arikawa M, Takanari K, Kadota H, Yanagisawa D, Tanaka K, Matsumoto H, Kimata Y, Miyamoto S, Sakuraba M, Kawai K, Terao Y, Hyodo I, Ishida K, Yoshimura K. Higashino T, et al. Among authors: tanaka k. Support Care Cancer. 2024 Dec 30;33(1):64. doi: 10.1007/s00520-024-09128-4. Support Care Cancer. 2024. PMID: 39738887
18,805 results
You have reached the last available page of results. Please see the User Guide for more information.